Revalesio, a pioneering biotechnology company based in Tacoma, recently signed an 18-month contract with the Katze lab at the UW to bring hope to sufferers of influenza, HIV and hepatitis C.
This annual course was first held in 1993 with the aim of offering an intensive overview of the skills needed to pursue a research career in the field of STD.